Main distributor to Brazil and Latin America for analytical reference substances  |  Welcome! Olá! Hola! Español  |  +1.919.484.7555
You are here: Home /Business, USA /GSK Collaborates on New Class of Medicines

GSK Collaborates on New Class of Medicines

by JMC on May 23, 2012

GlaxoSmithKline has partnered with the US’s Yale University to design a potential new class of medicines that could be beneficial in areas such as oncology, inflammation and infection.

The collaboration will combine GSK’s medicinal chemistry expertise with the university’s work on PROTACs, molecules that could potentially be used to degrade disease-causing proteins. PROTACs, proteolysis targeting chimeric molecules, have the ability to guide proteins to a cell’s cleaning mechanism, where they can then be destroyed.

Read more…

Previous post:

Next post: